News

The CDC began recommending Ixchiq last year for adults traveling to countries where chikungunya is common. The vaccine uses a ...
The decision follows ongoing investigations into serious adverse events primarily reported in elderly individuals who ...
The FDA and CDC recommended a pause in administering Ixchiq, a chikungunya vaccine, in adults ages 60 and above after 17 serious adverse events, including two deaths.  About 80,000 Ixchiq doses have ...
The FDA and CDC recommended a pause for Ixchiq, a chikungunya vaccine, following reports of adverse events in recipients 60 ...
On the heels of similar moves in France and the European Union, U.S. health authorities are calling for a pause in the use of ...
The U.S. government is advising that international travelers age 60 and older not get a chikungunya vaccine as it ...
Mosquitoes can tranmist dengue virus, which has already caused local cases in Florida in 2025... | Clinical And Molecular Dx ...